Conmed (CNMD) Invested Capital (2010 - 2026)

Conmed has reported Invested Capital for 17 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 8.17% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 8.17% YoY), and the FY2025 full-year result was $1.1 billion, up 11.45% from the prior year.
• Invested Capital for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
• The five-year high for Invested Capital was $1.1 billion in Q4 2025, with the low at $673.0 million in Q2 2022.
• Historically, Invested Capital has averaged $929.9 million across 5 years, with a median of $962.7 million in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital sank 31.09% — and 2024, when it gained 27.97%.
• Conmed's Invested Capital stood at $815.5 million in 2022, then increased by 16.28% to $948.3 million in 2023, then climbed by 1.52% to $962.7 million in 2024, then rose by 11.45% to $1.1 billion in 2025, then dropped by 1.44% to $1.1 billion in 2026.
• The last three Invested Capital figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.